Henlius Partners With Getz To Commercialize Adalimumab Biosimilar

Companies Plan To Cover 11 Emerging Markets In Asia, Africa And Europe

 
• By Akriti Seth

Henlius and Getz Pharma have partnered to commercialize Henlius’ adalimumab biosimilar in 11 emerging markets in Asia, Africa and Europe.

Emerging Market
Shanghai Henlius Biotech and Pakistan based Getz Pharma partner to commercialize adalimumab biosimilar in emerging markets • Source: Alamy

More from Biosimilars

More from Products